|
GB0305929D0
(en)
*
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
US7521457B2
(en)
*
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
TW200804364A
(en)
*
|
2006-02-22 |
2008-01-16 |
Boehringer Ingelheim Int |
New compounds
|
|
EP2007754A1
(en)
*
|
2006-04-10 |
2008-12-31 |
Boehringer Ingelheim International GmbH |
2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
|
|
PE20080068A1
(es)
*
|
2006-05-15 |
2008-03-17 |
Boehringer Ingelheim Int |
Compuestos derivados de pirimidina como inhibidores de la quinasa aurora
|
|
DE102006039003A1
(de)
|
2006-08-19 |
2008-02-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Verbindungen
|
|
EP2223925A1
(en)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
JP2010505962A
(ja)
|
2006-10-09 |
2010-02-25 |
武田薬品工業株式会社 |
キナーゼ阻害剤
|
|
MX2009004426A
(es)
|
2006-10-23 |
2009-08-12 |
Cephalon Inc |
Derivados biciclicos fusionados de 2,4-diaminopirimidina como inhibidores alk y c-met.
|
|
DE102007010801A1
(de)
|
2007-03-02 |
2008-09-04 |
Bayer Cropscience Ag |
Diaminopyrimidine als Fungizide
|
|
DK2146779T3
(en)
*
|
2007-04-18 |
2016-11-28 |
Pfizer Prod Inc |
Sulfonylamid derivatives to treat abnormal cell growth.
|
|
WO2008144222A2
(en)
*
|
2007-05-16 |
2008-11-27 |
Eli Lilly And Company |
Triazolyl aminopyrimidine compounds
|
|
CA2692502C
(en)
|
2007-07-05 |
2016-03-01 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
CN101796046A
(zh)
*
|
2007-07-16 |
2010-08-04 |
阿斯利康(瑞典)有限公司 |
嘧啶衍生物934
|
|
EP2188269B1
(de)
|
2007-08-14 |
2014-05-07 |
Boehringer Ingelheim International GmbH |
Arylsulfonamide mit analgetischer wirkung
|
|
EP2025675A1
(de)
|
2007-08-14 |
2009-02-18 |
Boehringer Ingelheim International GmbH |
Arylsulfonamide mit analgetischer Wirkung
|
|
WO2010017850A1
(de)
*
|
2008-08-12 |
2010-02-18 |
Boehringer Ingelheim International Gmbh |
Verfahren zur herstellung von cycloalkyl-substituierten piperazinverbindungen
|
|
US8278313B2
(en)
|
2008-03-11 |
2012-10-02 |
Abbott Laboratories |
Macrocyclic spiro pyrimidine derivatives
|
|
EP2100894A1
(en)
|
2008-03-12 |
2009-09-16 |
4Sc Ag |
Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
|
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
JP2011523646A
(ja)
|
2008-05-21 |
2011-08-18 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
キナーゼ阻害剤としてのリン誘導体
|
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
AU2009262068C1
(en)
*
|
2008-06-27 |
2015-07-02 |
Celgene Car Llc |
Heteroaryl compounds and uses thereof
|
|
EP2161259A1
(de)
|
2008-09-03 |
2010-03-10 |
Bayer CropScience AG |
4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
|
|
TW201024281A
(en)
|
2008-11-24 |
2010-07-01 |
Boehringer Ingelheim Int |
New compounds
|
|
AR074210A1
(es)
*
|
2008-11-24 |
2010-12-29 |
Boehringer Ingelheim Int |
Derivados de pirimidina como inhibidores de ptk2-quinasa
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
WO2010072155A1
(zh)
*
|
2008-12-26 |
2010-07-01 |
复旦大学 |
一种嘧啶类衍生物及其制备方法和用途
|
|
EP2382210B1
(en)
*
|
2008-12-30 |
2017-03-01 |
Rigel Pharmaceuticals, Inc. |
Pyrimidinediamine kinase inhibitors
|
|
US20110071158A1
(en)
*
|
2009-03-18 |
2011-03-24 |
Boehringer Ingelheim International Gmbh |
New compounds
|
|
ES2513915T3
(es)
*
|
2009-04-24 |
2014-10-27 |
F. Hoffmann-La Roche Ag |
Inhibidores de la tirosina quinasa de Bruton
|
|
KR101705158B1
(ko)
|
2009-05-05 |
2017-02-09 |
다나-파버 캔서 인스티튜트 인크. |
Ｅｇｆｒ 억제제 및 질환 치료방법
|
|
WO2010135524A1
(en)
*
|
2009-05-22 |
2010-11-25 |
Exelixis, Inc. |
Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
|
|
MX2011012584A
(es)
|
2009-05-26 |
2012-02-21 |
Exelixis Inc |
Benzoxazepinas como inhibidores de pi3k/m tor, metodos para su uso y fabricación.
|
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
HUE034911T2
(hu)
|
2009-07-27 |
2018-03-28 |
Gilead Sciences Inc |
Fúzionált heterociklusos vegyületek mint ioncsatorna modulátorok
|
|
US8933227B2
(en)
|
2009-08-14 |
2015-01-13 |
Boehringer Ingelheim International Gmbh |
Selective synthesis of functionalized pyrimidines
|
|
US8729265B2
(en)
|
2009-08-14 |
2014-05-20 |
Boehringer Ingelheim International Gmbh |
Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives
|
|
CN102713618B
(zh)
|
2009-09-16 |
2015-07-15 |
新基阿维罗米克斯研究公司 |
蛋白激酶复合物和抑制剂
|
|
WO2011082285A1
(en)
|
2009-12-30 |
2011-07-07 |
Avila Therapeutics, Inc. |
Ligand-directed covalent modification of protein
|
|
BR112012029647A2
(pt)
|
2010-05-21 |
2016-08-02 |
Chemilia Ab |
novos derivados de pirimidinas
|
|
AU2011260323A1
(en)
|
2010-06-04 |
2012-11-15 |
F. Hoffmann-La Roche Ag |
Aminopyrimidine derivatives as LRRK2 modulators
|
|
EP2588197B1
(en)
|
2010-07-02 |
2014-11-05 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as ion channel modulators
|
|
PH12013500246A1
(en)
|
2010-08-10 |
2019-10-11 |
Celgene Avilomics Res Inc |
Besylate salt of a btk inhibitor
|
|
JP5956999B2
(ja)
|
2010-11-01 |
2016-07-27 |
セルジーン アヴィロミクス リサーチ， インコーポレイテッド |
ヘテロアリール化合物およびその使用
|
|
BR112013010564B1
(pt)
|
2010-11-01 |
2021-09-21 |
Celgene Car Llc |
Compostos heterocíclicos e composições compreendendo os mesmos
|
|
KR101566091B1
(ko)
|
2010-11-10 |
2015-11-04 |
에프. 호프만-라 로슈 아게 |
Lrrk2 조절제로서 피라졸 아미노피리미딘 유도체
|
|
EP2637502B1
(en)
|
2010-11-10 |
2018-01-10 |
Celgene CAR LLC |
Mutant-selective egfr inhibitors and uses thereof
|
|
WO2012074951A1
(en)
|
2010-11-29 |
2012-06-07 |
OSI Pharmaceuticals, LLC |
Macrocyclic kinase inhibitors
|
|
US8546443B2
(en)
|
2010-12-21 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Benzylic oxindole pyrimidines
|
|
MX2013010898A
(es)
|
2011-03-24 |
2013-12-06 |
Chemilia Ab |
Novedoso derivados de la pirimidina.
|
|
AU2012250517B2
(en)
|
2011-05-04 |
2016-05-19 |
Takeda Pharmaceutical Company Limited |
Compounds for inhibiting cell proliferation in EGFR-driven cancers
|
|
WO2012154760A1
(en)
|
2011-05-10 |
2012-11-15 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as sodium channel modulators
|
|
NO3175985T3
(enExample)
|
2011-07-01 |
2018-04-28 |
|
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
JP2014532658A
(ja)
|
2011-10-28 |
2014-12-08 |
セルジーン アヴィロミクス リサーチ， インコーポレイテッド |
ブルトン型チロシンキナーゼ疾患または障害を治療する方法
|
|
EP2802579B1
(en)
|
2012-01-13 |
2016-04-13 |
Bristol-Myers Squibb Company |
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
|
|
WO2013106614A1
(en)
|
2012-01-13 |
2013-07-18 |
Bristol-Myers Squibb Company |
Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
|
|
ES2686500T3
(es)
|
2012-01-13 |
2018-10-18 |
Bristol-Myers Squibb Company |
Compuestos de piridilo sustituidos con heterocíclicos, útiles como inhibidores de cinasas
|
|
JP6317320B2
(ja)
|
2012-03-15 |
2018-04-25 |
セルジーン シーエーアール エルエルシー |
上皮成長因子受容体キナーゼ阻害剤の塩
|
|
ES2880109T3
(es)
|
2012-03-15 |
2021-11-23 |
Celgene Car Llc |
Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico
|
|
JP6469567B2
(ja)
|
2012-05-05 |
2019-02-13 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
Ｅｇｆｒ発動性がんの細胞増殖阻害用化合物
|
|
HK1209414A1
(en)
*
|
2012-10-18 |
2016-04-01 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
CN104781251B
(zh)
|
2012-11-08 |
2016-12-14 |
百时美施贵宝公司 |
可作为激酶调节剂的经双环杂环取代的吡啶基化合物
|
|
AU2013341200A1
(en)
|
2012-11-08 |
2015-07-02 |
Bristol-Myers Squibb Company |
Heteroaryl substituted pyridyl compounds useful as kinase modulators
|
|
US9126950B2
(en)
|
2012-12-21 |
2015-09-08 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
CN105188371A
(zh)
|
2013-02-08 |
2015-12-23 |
西建阿维拉米斯研究公司 |
Erk抑制剂及其用途
|
|
JP6091248B2
(ja)
*
|
2013-02-22 |
2017-03-08 |
キヤノン株式会社 |
プリンタ
|
|
CA2903979A1
(en)
|
2013-03-14 |
2014-09-18 |
Novartis Ag |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
|
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
TW201609693A
(zh)
|
2014-01-03 |
2016-03-16 |
必治妥美雅史谷比公司 |
雜芳基取代之菸鹼醯胺化合物
|
|
WO2016025561A1
(en)
|
2014-08-13 |
2016-02-18 |
Celgene Avilomics Research, Inc. |
Forms and compositions of an erk inhibitor
|
|
EP3313844B1
(en)
|
2015-06-24 |
2020-08-26 |
Bristol-Myers Squibb Company |
Heteroaryl substituted aminopyridine compounds
|
|
CN107849039B
(zh)
|
2015-06-24 |
2020-07-03 |
百时美施贵宝公司 |
经杂芳基取代的氨基吡啶化合物
|
|
TW201713655A
(zh)
|
2015-06-24 |
2017-04-16 |
必治妥美雅史谷比公司 |
經雜芳基取代之胺基吡啶化合物
|
|
WO2017016668A1
(en)
*
|
2015-07-29 |
2017-02-02 |
Laboratorios Del Dr. Esteve, S.A. |
Amide derivatives having multimodal activity against pain
|
|
TWI724056B
(zh)
*
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Ｃｘｃｒ２抑制劑
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
CN106831730B
(zh)
*
|
2017-01-11 |
2019-11-26 |
温州医科大学 |
一种取代的二氨基嘧啶类化合物及其在制备抗恶性肿瘤药物中的用途
|
|
CA3062602A1
(en)
|
2017-05-11 |
2018-11-15 |
Bristol-Myers Squibb Company |
Thienopyridines and benzothiophenes useful as irak4 inhibitors
|
|
ES3067325T3
(en)
|
2018-01-08 |
2026-05-21 |
Chemocentryx Inc |
Methods of treating generalized pustular psoriasis with an antagonist of ccr6 or cxcr2
|
|
JP7620611B2
(ja)
|
2019-07-18 |
2025-01-23 |
ブリストル－マイヤーズ スクイブ カンパニー |
ＩＲＡＫ４阻害剤として有用なピラゾロ［３，４－ｄ］ピロロ［１，２－ｂ］ピリダジニル化合物
|
|
WO2021011724A1
(en)
|
2019-07-18 |
2021-01-21 |
Bristol-Myers Squibb Company |
Tricyclic heteroaryl compounds useful as irak4 inhibitors
|
|
EP4010317B1
(en)
|
2019-08-06 |
2024-06-19 |
Bristol-Myers Squibb Company |
Bicyclic heterocyclic compounds useful as irak4 inhibitors
|
|
CN114206874B
(zh)
|
2019-08-13 |
2024-08-02 |
百时美施贵宝公司 |
可用作irak4抑制剂的双环杂芳基化合物
|
|
US12643891B2
(en)
*
|
2019-12-06 |
2026-06-02 |
Yale University |
SPAK/OSR inhibitors and methods of using same
|
|
EP4100408B1
(en)
|
2020-02-03 |
2024-02-28 |
Bristol-Myers Squibb Company |
Tricyclic heteroaryl compounds useful as irak4 inhibitors
|
|
WO2021158495A1
(en)
|
2020-02-03 |
2021-08-12 |
Bristol-Myers Squibb Company |
Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as irak4 inhibitors
|
|
US12643886B2
(en)
|
2021-01-07 |
2026-06-02 |
Ontario Institute for Cancer Research (OICR), The Governing Council of the University of Toronto, Sinai Health System |
Isoindolinone aminopyrimidine compounds as inhibitors of NUAK kinases, compositions and uses thereof
|
|
CN118574825A
(zh)
*
|
2022-02-28 |
2024-08-30 |
微境生物医药科技(上海)有限公司 |
作为fak抑制剂的化合物及其用途
|
|
WO2024051717A1
(zh)
*
|
2022-09-08 |
2024-03-14 |
上海深势唯思科技有限责任公司 |
作为plk1抑制剂的化合物及其制备方法和用途
|
|
CN119285624B
(zh)
*
|
2024-09-25 |
2025-09-23 |
南方医科大学中西医结合医院 |
一种含噻吩的嘧啶类化合物及其制备方法与在制备具有抗癌作用的药物中的应用
|